GRASP MRI Longitudinal Imaging for Brain Metastasis Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current imaging techniques, such as standard MRI, struggle to accurately differentiate between brain metastasis progression and radiation effects or necrosis, necessitating improved methods for precise diagnostic differentiation.
Innovation Solution
Utilizing GRASP dynamic contrast-enhanced MRI with high spatial and temporal resolution to analyze tissue enhancement, employing normalized wash-in slope as a model-free measure to distinguish between tumor progression and radiation necrosis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If standard MRI imaging is used, then the imaging process is simple and quick, but the ability to differentiate between tumor progression and radiation effects is insufficient
Solution Approach 1:
The patent employs dynamic contrast-enhanced MRI with continuous temporal sampling to capture the temporal evolution of contrast agent uptake. By analyzing the dynamic wash-in and wash-out patterns over time rather than static images, the system achieves superior differentiation between tumor progression and radiation effects, resolving the contradiction between simplicity and differentiation accuracy.
Solution Approach 2:
The patent transforms standard MRI into a quantitative diagnostic tool by measuring and analyzing physiological parameters such as wash-in slope, wash-out rate, and contrast enhancement kinetics. These parameter changes in tissue perfusion and permeability provide objective metrics for differentiation, overcoming the limitations of visual assessment while maintaining clinical applicability.
2Reliability
If longitudinal follow-up imaging is performed to monitor treatment response, then diagnostic accuracy improves, but the time and resource investment increases
Solution Approach 1:
The patent establishes baseline GRASP MRI measurements before treatment to create a reference profile for each patient. This preliminary action enables subsequent comparisons to detect early treatment responses or progressions, improving diagnostic reliability without requiring extensive longitudinal follow-up and reducing the time investment needed for monitoring.
Solution Approach 2:
The patent implements a feedback mechanism where quantitative metrics from GRASP MRI (such as wash-in slope and enhancement patterns) are continuously monitored and compared to baseline and historical data. This feedback loop enables early detection of treatment response or progression, allowing timely clinical decisions and reducing the need for prolonged follow-up imaging.
Data Source
AI summary
A method can include receiving, by at least one processor, a magnetic resonance dataset comprising at least one scan. The method can include performing, by the at least one processor, golden-angle radial sparse parallel imaging on the magnetic resonance dataset to output one or more images. The method can include identifying, by the at least one processor, at least one region of interest in the one or more images, the at least one region of interest corresponding to at least one of tumor progression or radiation effects.